Status:
COMPLETED
Comparing the Burden of Illness of Hemophilia in the Developing and the Developed World
Lead Sponsor:
The Hospital for Sick Children
Conditions:
Hemophilia A
Hemophilia B
Eligibility:
MALE
7-18 years
Brief Summary
Because of high cost, persons with hemophilia in many developing countries cannot afford adequate treatment. For example, many persons with hemophilia in India and China are only rarely treated with f...
Detailed Description
In order to quantify the burden of illness in hemophilia, and to study the response to different treatments, it is necessary to have quantitative outcome measures of high validity and reliability. The...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Hemophilia A or B moderate or severe as determined by serum factor activity ≤ 5%
- Age 7 - 18 yrs. inclusive
- At least one parent or guardian fluent in written Portuguese or English and able to complete the study outcome questionnaires.
- Exclusion criteria
- None (Children with inhibitors will be allowed into the study for 2 reasons: i) our study aims to document the health of persons with hemophilia in a generalizable way, ii) not all children will have had inhibitor testing done.)
Exclusion
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01217255
Start Date
September 1 2010
End Date
October 1 2013
Last Update
June 6 2018
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade Estadual de Campinas, UNICAMP
Campinas, São Paulo, Brazil
2
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
São Paulo, Brazil
3
Universidade Federal de São Paulo (UNIFESP)
São Paulo, Brazil
4
The Hospital for Sick Children
Toronto, Ontario, Canada, M5G 1X8